Showing results (71-80 of 2,405) with videos related to
Sort By:
Pageof 241
Journal of Medical Economics|March 11, 2021
Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United StatesRongzhe Liu, Olalekan O Oluwole, Ibrahim Diakite, et al.Journal of Medical Economics|September 9, 2022
Place of care and costs associated with acute episodes and remission in bipolar I disorderRoger S McIntyre, Sara Higa, Quan V Doan, et al.Journal of Medical Economics|April 29, 2011
Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infantsNianwen Shi, Liisa Palmer, Bong-Chul Chu, et al.Journal of Medical Economics|June 25, 2011
Systematic literature review of economics analysis on treatment of mild-to-moderate bleeds with aPCC versus rFVIIaJoel W Hay, Zheng-Yi ZhouJournal of Medical Economics|June 10, 2011
Cost effectiveness of duloxetine in the treatment of fibromyalgia in the United StatesS M Beard, N Roskell, T K Le, et al.Journal of Medical Economics|June 10, 2011
A review of biopsychosocial strategies to prevent and overcome early-recognized poor adherence in growth hormone therapy of childrenFritz Haverkamp, Christoph GasteygerJournal of Medical Economics|September 5, 2015
A new angle for glp-1 receptor agonist: the medical economics argument. Editorial on: Huetson P, Palmer JL, Levorsen A, et al. Cost-effectiveness of the once-daily glp-1 receptor agonist lixisenatide compared to bolus insulin both in combination with basal insulin for the treatment of patients with type 2 diabetes in Norway. J Med Econ 2015: 1-13 [Epub ahead of print]Willy Marcos Valencia, Hermes Jose FlorezJournal of Medical Economics|September 5, 2015
Treatment patterns and annual biologic costs in US veterans with rheumatic conditions or psoriasisBrian C Sauer, Chia-Chen Teng, Tao He, et al.Journal of Medical Economics|December 27, 2015
Relationship of hospital-associated bleeding with length of stay and total hospitalization costs in patients hospitalized for atrial fibrillationAlpesh N Amin, Scott B Robinson, Bruce D Bowdy, et al.Journal of Medical Economics|January 30, 2016
Co-calibrating quality-of-life scores from three pulmonary disorders: implications for comparative-effectiveness researchM Rouse, J Twiss, S P McKennaPageof 241